Post-Market, Long-Term Follow Up of Mobi-C® Cervical Disc for One and Two Level Treatment of Cervical Disc Disease
Condition(s):Cervical Disc Disease; Cervical Disc DegenerationLast Updated:December 4, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Cervical Disc Disease; Cervical Disc DegenerationLast Updated:December 4, 2019Completed
Condition(s):OsteoarthritisLast Updated:March 11, 2015Completed
Condition(s):Contraception; Bleeding PatternLast Updated:April 30, 2019Completed
Condition(s):Arthritis, RheumatoidLast Updated:July 9, 2014Completed
Condition(s):OsteoarthritisLast Updated:November 24, 2023Completed
Condition(s):HealthyLast Updated:July 8, 2014Completed
Condition(s):HealthyLast Updated:July 8, 2014Completed
Condition(s):HealthyLast Updated:April 1, 2008Completed
Condition(s):HealthyLast Updated:April 1, 2008Completed
Condition(s):Arthritis, RheumatoidLast Updated:July 8, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.